Otofarma S.P.A. (BIT:OTO)

Otofarma S.P.A. Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Aug 17, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.35	0.35	0.56
Debt / EBITDA Ratio	0.51	0.51	1.14
Debt / FCF Ratio	0.82	0.82	3.81
Net Debt / Equity Ratio	-0.12	-0.12	0.28
Net Debt / EBITDA Ratio	-0.18	-0.18	0.58
Net Debt / FCF Ratio	-0.28	-0.28	1.93
Asset Turnover	1.87	1.87	-
Inventory Turnover	34.08	34.08	-
Quick Ratio	2.13	2.13	2.03
Current Ratio	2.24	2.24	2.12
Return on Equity (ROE)	56.87%	56.87%	-
Return on Assets (ROA)	25.84%	25.84%	-
Return on Invested Capital (ROIC)	57.50%	57.50%	24.18%
Return on Capital Employed (ROCE)	54.10%	54.10%	33.90%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Aug 15, 2026

Data Sources Report a data error